Table 1.
Baseline characteristics of the study groups
| Good neurologic group (n = 34) | Poor neurologic group (n = 42) | P value | |
|---|---|---|---|
| Age |
47.9 ± 15.9 |
54.9 ± 16.3 |
0.06 |
| Gender male (%) |
24 (70.6) |
24 (57.1) |
0.22 |
| Weight (kg) |
62.5 ± 13.6 |
61.7 ± 8.5 |
0.76 |
| Height (cm) |
167.1 ± 7.6 |
164.7 ± 8.6 |
0.22 |
| Body mass index |
22.2 ± 3.7 |
22.7 ± 2.1 |
0.51 |
| Underlying disease |
|
|
|
| Hypertension (%) |
8 (23.5) |
9 (21.4) |
0.82 |
| Diabetics (%) |
4 (11.8) |
6 (14.3) |
0.74 |
| Heart disease (%) |
5 (14.7) |
5 (11.9) |
0.72 |
| Chronic renal disease (%) |
2 (5.8) |
3 (7.1) |
0.82 |
| Malignancy (%) |
4 (11.8) |
3 (7.1) |
0.49 |
| Arrest cause (%) |
|
|
<0.01 |
| Cardiac |
33 (97.1) |
19 (45.2) |
|
| Respiratory |
1 (2.9) |
22 (52.4) |
|
| Other |
0 (0) |
1 (2.4) |
|
| Bystander CPR (%) |
18 (52.9) |
9 (21.4) |
<0.01 |
| AED apply (%) |
26 (76.4) |
28 (66.7) |
0.34 |
| AED shock (%) |
23 (67.7) |
10 (23.8) |
<0.01 |
| No-flow time (minutes) |
3.5 ± 3.8 |
12.7 ± 9.5 |
<0.01 |
| Low-flow time (minutes) |
22.9 ± 21.2 |
26.2 ± 15.8 |
0.43 |
| BLS time (minutes) |
10.3 ± 7.8 |
12.7 ± 9.2 |
0.22 |
| ACLS time (minutes) |
12.5 ± 19.2 |
13.4 ± 11.7 |
0.79 |
| Initial rhythms (%) |
|
|
<0.01 |
| Ventricular fibrillation |
24 (70.6) |
9 (21.4) |
|
| Pulseless electrical activity |
8 (23.5) |
16 (38.1) |
|
| Asystole |
2 (5.9) |
17 (40.5) |
|
| Hypothermia therapy induction time |
194.6 ± 92.2 |
179 ± 113.5 |
0.53 |
| Organ failure rate |
|
|
|
| Heart (%) |
24 (70.6) |
26 (61.9) |
0.42 |
| Lung (%) |
19 (55.8) |
26 (61.9) |
0.59 |
| Liver (%) |
0 (0.0) |
0 (0.0) |
– |
| Kidney (%) |
6 (17.7) |
2 (4.7) |
0.06 |
| Coagulation (%) |
2 (6.1) |
3 (8.1) |
0.74 |
| SOFA score (median) | 6 (3 to 7) | 5 (2 to 7) | 0.66 |
Data presented as mean ± standard deviation, n (%) or median (interquartile range). AED, automated external defibrillator; BLS, basic life support; ACLS, advanced cardiac life support; CPR, cardiopulmonary resuscitation; SOFA, Sequential Organ Failure Assessment.